Adaptimmune Therapeutics plc

ADAPNASDAQHealthcare

$0.05

$-0.00(-3.00%)

Market Cap$75157679

P/E Ratio—

52W High$0.86

52W Low$0.0202

Avg Volume110.6M

Open$0.04

Beta2.49

Overview

Adaptimmune Therapeutics plc (ADAP) Number of Employees – History & Annual Headcount

Annual SEC headcount, year-over-year change, and per-employee efficiency — chart and full history below.

SEC EDGAR · FMP · ADAP · as of Mar 24, 2025

Latest filing snapshot

506

+57+12.69%vs prior year

Adaptimmune Therapeutics plc (ADAP) employee data is sourced from the annual SEC 10-K filing. As of 2024, full-time employees only. Global consolidated headcount. View SEC filing ↗

SEC 10-K·Period end: 2024-12-31·Full-time · Global

Total Employees

506

Change (1Y)

+57

Growth % (1Y)

+12.69%

Revenue / Employee

$351.8K

Net Income / Employee

$-139.9K

Market Cap

$75M

ADAP Employee Count

2015 – 2024 · Annual · SEC filing

Source: SEC annual filings · Hover bar to view year data · Click to view original filing

Employees History

Filing Date	Period End	Employees	Change (1Y)	Growth (1Y)
2025-03-24	2024-12-31	506	+57	+12.69%
2024-03-06	2023-12-31	449	-85	-15.92%
2023-03-06	2022-12-31	534	+40	+8.10%
2022-03-14	2021-12-31	494	+32	+6.93%
2021-02-25	2020-12-31	462	+62	+15.50%
2020-02-27	2019-12-31	400	-30	-6.98%
2019-02-27	2018-12-31	430	+59	+15.90%
2018-03-15	2017-12-31	371	+73	+24.50%
2017-03-13	2016-12-31	298	+219	+277.22%
2016-03-17	2015-12-31	79	+0	+0.00%

▸ Source: SEC Annual Reports (Form 10-K / 20-F). Employee counts as of fiscal year end. Click the ↗ icon at the end of a row to open the original SEC filing in a new tab.

Related Companies — Employee Count

Biotechnology

#SymbolCompanyEmployeesMkt Cap

ADAP

Adaptimmune Therapeutics plcYOU

LNAI

Lunai Bioworks Inc.

29$11M

Ernexa Therapeutics Inc.

6$2M

Source: /stock-peers + /profile.fullTimeEmployees · Click row → /employees · Sorted by headcount · ADAP peer comparison

About ADAP employees

ADAP Employees · Headcount

Adaptimmune Therapeutics plc (ADAP) employee data is sourced from the annual SEC 10-K filing. As of 2024, Adaptimmune Therapeutics plc had 506 full-time employees globally. Full-time employees only. Global consolidated headcount.

Adaptimmune Therapeutics plc employs 506 full-time employees as of the latest filing within the Biotechnology industry. Revenue per employee stands at $351,842, reflecting the company's operational efficiency.

Adaptimmune Therapeutics plc's workforce increased by 57 (12.69%) in 2024 compared to the prior fiscal year. The historical trend reflects the company's expansion and contraction cycles.

Adaptimmune Therapeutics plc's revenue per employee of $351,842 positions it among the notable performers in the Biotechnology sector for operational efficiency.

Revenue Financial statements Net income SEC filings Price history Forecast & ratings Ownership Earnings

Frequently Asked Questions

ADAP Employees · 5 questions

As of the latest SEC 10-K filing (2024), Adaptimmune Therapeutics plc had 506 full-time employees globally. This figure is sourced from the company's mandatory annual disclosure to the SEC.

Adaptimmune Therapeutics plc employee counthow many employees does Adaptimmune Therapeutics plc haveADAP total employees 2024

▸ Data source: FMP /historical-employee-count · SEC EDGAR annual filings · As reported · Global consolidated headcount · As of 2025-03-24